Jeevan Scientific Technology

Jeevan Scientific Technology ROE

The Return on Equity (ROE) of Jeevan Scientific Technology (538837.BO) as of Oct 21, 2026 is 1.60 %. In the previous year, Return on Equity (ROE) was 0.27 % — a change of 495.59% (higher).

ROE

1.60 %

YoY

495.59%

Last updated:

In 2026, Jeevan Scientific Technology's return on equity (ROE) was 1.60 %, a 495.59% increase from the 0.27 % ROE in the previous year.

The Jeevan Scientific Technology ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2019
3.50 INR
Jan 1, 2020
-36.97 INR
Jan 1, 2021
33.52 INR
Jan 1, 2022
24.24 INR
Jan 1, 2023
-6.34 INR
Jan 1, 2024
-2.68 INR
Jan 1, 2025
0.27 INR
Jan 1, 2026
1.60 INR
The Jeevan Scientific Technology ROE history
YEARROEYoY
1.60 %+495.59%
0.27 %-110.06%
-2.68 %-57.81%
-6.34 %-126.17%
24.24 %-27.68%
33.52 %-190.67%
-36.97 %-1,156.50%
3.50 %+610.82%
0.49 %-90.80%
5.35 %-1,351.41%
-0.43 %-101.12%
38.02 %+291.45%
9.71 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Jeevan Scientific Technology Stock analysis

What does Jeevan Scientific Technology do? Jeevan Scientific Technology Ltd generates revenue by providing global management consulting and technology services through its core segments of clinical research and information technology. The company leverages its expertise in outsourcing to support clients with a comprehensive suite of offerings, including clinical operations, bioanalytical research, and pathology laboratory services. These capabilities are structured to address specific needs within the pharmaceutical and healthcare sectors, ensuring robust support for complex scientific and regulatory requirements. The firm monetizes its clinical research services by delivering specialized solutions such as bioanalytical and bioequivalence studies, clinical trials, and trial management. Additional revenue streams are created through pharmacovigilance services, which encompass risk management plans and signal detection. The company also provides essential support functions like medical writing, clinical trial monitoring, drug safety management, and clinical data management, thereby offering end-to-end solutions for its clients. In the information technology segment, Jeevan Scientific Technology Ltd complements its scientific services with technical expertise in biostatistics, statistical programming, and quality assurance. By integrating these IT services with its clinical research capabilities, the company delivers a unified value proposition to its customer base. This integrated approach allows the firm to capture value across multiple touchpoints in the clinical development lifecycle, from initial study design to final data analysis and safety monitoring. Jeevan Scientific Technology is one of the most popular companies on Eulerpool.

ROE Details

Decoding Jeevan Scientific Technology's Return on Equity (ROE)

Jeevan Scientific Technology's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Jeevan Scientific Technology's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Jeevan Scientific Technology's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Jeevan Scientific Technology’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Jeevan Scientific Technology stock

Return on Equity (ROE) of Jeevan Scientific Technology is 1.60 % in 2026.

Return on Equity (ROE) of Jeevan Scientific Technology changed from 0.27 % to 1.60 %, representing a 495.59% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Jeevan Scientific Technology since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Jeevan Scientific Technology with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Jeevan Scientific Technology

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Jeevan Scientific Technology